Ignazio Caruana

18PUBLICATIONS
68CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 09, 2026
Multifunctional-engineered NK cells overcome tumor immunosuppression by combining PD-L1 and HLA-E targeting and endogenous IL15 production.

|Jun 01, 2026
Autophagy supports the storage of lytic granules in human NK cells.

|Aug 27, 2024
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8<sup>+</sup> T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi

|Apr 05, 2023
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

Francesca Del Bufalo, Biagio De Angelis, Ignazio Caruana

|Feb 25, 2023
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy.

Sara Pagotto, Pasquale Simeone, Davide Brocco

|Nov 13, 2021
Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma.

Nicola Tumino, Gerrit Weber, Francesca Besi

Pageof 3

Frequent Collaborators

3 joint publications

Bruno Azzarone

3 joint publications

Francesca Del Bufalo

3 joint publications

Andrea Pelosi

3 joint publications

Silvia Campello